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Objectives. The present study sought to determine whether
myocardial contractile abnormalities accompany the development
of chest pain in patients with normal coronary angiograms.
Background. The mechanism of chest pain in patients with
angina despite a normal coronary arteriogram is controversial.
Although previous studies postulated the existence of coronary
microvascular dysfunction, others failed to find evidence of myo-
cardial ischemia, and recent studies have demonstrated abnormal
cardiac sensitivity in these patients that can lead to chest pain on
a nonischemic basis.
Methods. Seventy patients (26 men and 44 women, mean age
49 6 10 years) with angina-like chest pain and angiographically
normal coronary arteries underwent exercise treadmill testing,
radionuclide angiography at rest and during exercise, thallium
stress testing and transesophageal dobutamine stress echocardi-
ography. The results of exercise treadmill testing and stress
echocardiography were compared with those obtained in 26
normal control subjects (19 men and 7 women, mean age 56 6 7
years).
Results. Abnormalities consistent with myocardial ischemia
were noted in 31% of the patients during exercise treadmill
testing, in 16% during exercise radionuclide angiography and in
18% during thallium stress testing. The findings of the radionu-
clide studies were not concordant with one another and were not
related to the presence of repolarization changes during exercise
testing. During infusion of dobutamine, chest pain developed in 59
patients (84%) and in none of the control subjects (p < 0.0001);
repolarization changes occurred in 22 patients (34%) and in 2
control subjects (8%) (p < 0.04). None of the patients or the
control subjects developed regional wall motion abnormalities
with dobutamine. The quantitative myocardial contractile re-
sponse to dobutamine was similar in patients and control sub-
jects, with an 80% power to detect a 25% difference in systolic wall
thickening at the maximal dose of dobutamine.
Conclusions. There was no agreement in the results of nonin-
vasive tests in our patients. Despite the frequent provocation of
chest pain and electrocardiographic abnormalities with dobut-
amine, the patients demonstrated a quantitatively normal myo-
cardial contractile response without development of wall motion
abnormalities. These observations strongly suggest that myocar-
dial ischemia is not the cause of chest pain in patients with a
normal coronary arteriogram.
(J Am Coll Cardiol 1997;29:293–301)
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The occurrence of angina-like chest pain in patients without
evidence of obstructive coronary artery disease is a puzzling
but not uncommon observation in clinical practice. In fact,
;20% of patients undergoing cardiac catheterization for in-
vestigation of chest pain have normal coronary arteriograms
(1–3). A similar frequency of normal coronary arteriograms
has been reported in patients with persistent chest pain after
successful coronary angioplasty (4). The mechanism of chest
pain in this condition is controversial (5). Previous investiga-
tors have postulated the existence of a coronary microvascular
abnormality that would lead to myocardial ischemia and chest
pain as a consequence of inappropriate vasodilator response to
increases in myocardial oxygen demands (6–21). However,
other workers have failed to find hemodynamic or metabolic
evidence of myocardial ischemia, even in those patients who
showed repolarization abnormalities during exercise, com-
monly referred to as syndrome X (22–27). Furthermore, in
most of these patients, symptoms are not alleviated by anti-
ischemic therapy (2,5). Finally, recent studies have demon-
strated the existence of abnormal cardiac sensitivity in these
patients associated with provocation of angina-like chest pain
on a nonischemic basis (28–33). These observations, therefore,
cast doubt on the occurrence of myocardial ischemia as the
cause of chest pain in patients with normal coronary arterio-
grams.
Stress echocardiography is an accepted methodology for the
assessment of induced myocardial ischemia in patients with
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obstructive coronary artery disease (34,35). Previous studies
using this method failed to identify induced wall motion
abnormalities in patients with chest pain, exercise-induced
repolarization abnormalities and normal coronary arterio-
grams (25,36,37). However, given the inherent limitations of
the transthoracic ultrasound examination and the regional
analysis of wall motion, it is possible that a mild degree of
circumferential or “patchy” ischemia may have been missed in
those studies. Among the stressors used in combination with
echocardiography for provocation of myocardial ischemia, the
infusion of dobutamine has recently gained popularity mainly
because the induced increases in myocardial oxygen demand
resemble those observed during exercise, the most physiologic
form of stress (38–40), and may be particularly useful in
patients with poor exercise capacity. We and other investiga-
tors have shown that transesophageal echocardiography during
dobutamine infusion is safe and accurate for the identification
of myocardial ischemia in patients with coronary artery disease
(41,42). This technique permits the acquisition of high quality
images in virtually every patient and therefore circumvents the
limitations of the transthoracic examination.
In the present investigation, we used a technique that has
been shown to be highly sensitive and specific for the assess-
ment of myocardial ischemia to address the question of
whether patients with chest pain and normal coronary angio-
grams have myocardial ischemia during the provocation of
chest pain, and we compared their results to those obtained in
a group of normal control subjects. The purpose of the study
was to gain insight into the mechanisms that determine the
occurrence of chest pain in the absence of stenotic lesions of
the epicardial coronary arteries.
Methods
Study group. Seventy patients admitted to the Clinical
Center of the National Institutes of Health for evaluation of
angina-like chest pain who showed normal or near normal
(epicardial coronary stenoses ,30%) coronary arteries at the
time of cardiac catheterization were included in the study. The
patients included in the study had chest pain that, because of
its characteristic location, nature, radiation and associated
symptoms, prompted the referring physician to perform a
cardiac catheterization to rule out the presence of obstructive
coronary artery disease. Patients were not selected for partic-
ipation in this study based on results of prior noninvasive stress
testing. There were 26 men and 44 women whose mean age
was 496 10 years (range 33 to 73). The mean duration of chest
pain was 4 6 5 years (range 0.5 to 28). Each patient had
normal left ventricular systolic function at rest. Six of the 70
patients had persistent chest pain after previous successful
coronary angioplasties and demonstrated coronary stenoses
,30% at the time of repeat catheterization. Although these
patients had evidence of coronary atherosclerosis and are
therefore different, in terms of their coronary pathophysiology,
from patients with perfectly smooth coronary arteries, they
both constitute part of the dilemma of the occurrence of chest
pain in the absence of obstructive coronary artery lesions and
were therefore included in the present study. Patients with left
bundle branch block at rest or during exercise stress, evidence
of cardiomyopathy, left ventricular hypertrophy, congenital or
valvular heart disease, myocardial infarction, unstable angina
or uncontrolled systemic hypertension were excluded from the
study. Fourteen patients had a history of mild essential hyper-
tension, but none of them had echocardiographic evidence of
left ventricular hypertrophy. All patients were in sinus rhythm.
Antianginal medications were withdrawn at least 48 h before
the performance of studies.
A population of 26 normal volunteers was selected as a
control group. There were 19 men and 7 women whose mean
age was 56 6 7 years (range 42 to 66). These subjects were
screened by history, physical examination, electrocardiogram
(ECG), chest X-ray film and chemical analyses. They had no
evidence of cardiovascular disease or any other systemic
condition and had no history of chest pain. Six control subjects
had systolic blood pressure .145 mm Hg (but ,155 mm Hg)
during the baseline measurements obtained before infusing
dobutamine. Similarly, six subjects had systolic blood pressure
.145 mm Hg (but ,155 mm Hg) immediately before the
performance of exercise testing. Of note, only two of the
subjects had such a mild elevation in blood pressure on both
tests, and none had elevation (.90 mm Hg) of diastolic blood
pressure. None of the control subjects was taking any medica-
tion.
The two groups represent a consecutive series of subjects
fulfilling eligibility criteria who underwent this testing. In each
patient, all studies were performed within 1 week. The study
was approved by the National Heart, Lung and Blood Institute
Investigational Review Board and participants gave written
informed consent for all procedures.
Exercise testing. Patients underwent conventional symptom-
limited exercise testing using either the standard Bruce proto-
col (43) or the National Institutes of Health combined protocol
(44). The test was considered positive when planar or
downsloping ST segment depression of at least 1 mm at 0.08 s
after the J point was observed.
Radionuclide studies. Sixty-two patients with chest pain
and normal coronary arteries also underwent radionuclide
angiography and thallium scintigraphy, and the images were
analyzed by an independent reviewer who was unaware of the
dobutamine echocardiographic results. The remaining eight
patients did not complete both radionuclide studies because of
their inability to exercise on a bicycle ergometer (three pa-
tients) or because of inadequate images during exercise using
thallium scintigraphy (three patients) or radionuclide angiog-
raphy (two patients).
Gated blood pool cardiac scintigraphy was performed to
assess left ventricular ejection fraction and regional wall
motion at rest and during peak exercise using red blood cells
labeled in vivo with 20 to 25 mCi of technetium-99m, as
previously described (45). Left ventricular ejection fraction
during baseline conditions and at peak exercise was derived by
computer analysis of the scintigraphic data, and regional wall
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motion was assessed qualitatively by two experienced observers
from the images displayed in cineangiographic format. The
lower limit of normal for rest ejection fraction by our tech-
nique is 45%.
Patients underwent exercise thallium-201 single-photon
emission computed tomography using the standard Bruce
protocol. At peak exercise, 2 to 3 mCi of thallium-201 was
administered intravenously, and the patient continued to ex-
ercise for an additional 45 to 60 s followed by acquisition of
stress images. Approximately 3 to 4 h after redistribution of
thallium-201, an additional 1-mCi dose of thallium-201 was
reinjected at rest, and reinjection images were acquired
;15 min thereafter (46). From the raw scintigraphic data,
horizontal long-axis, vertical long-axis and short-axis tomo-
grams were reconstructed, and the distribution of thallium was
analyzed qualitatively in the anterior, apical, septal, inferior
and lateral regions. A region was considered to be reversible
(and therefore show evidence of myocardial ischemia) if
abnormally reduced thallium activity on stress images im-
proved or normalized on subsequent reinjection images.
Transesophageal dobutamine stress echocardiography.
Transesophageal echocardiograms were performed with a
Hewlett Packard biplane (24 subjects) or omniplane (72 sub-
jects) 5-MHz probe as previously described in detail (41).
Dobutamine was infused starting at 5 mg/kg body weight per
min. Subsequently, the dose was increased by either 5 or
10 mg/kg per min every 5 min to a maximum of 40 mg/kg per
min. At baseline and during the last 2 min of each stage of the
dobutamine infusion, transgastric short-axis and transesopha-
geal long-axis four- and two-chamber views were obtained.
Two-dimensional views were continuously recorded on video-
tape and digitized on-line using an Image Vue system (Nova
Microsonics). Images were transferred to optical disks for
permanent storage and review. A 12-lead ECG and measure-
ments of systemic blood pressure were recorded at baseline
and at the end of each stage. The test was terminated when the
maximal dose of dobutamine (40 mg/kg per min) was reached
or when severe chest pain, a severe increase in systolic blood
pressure (to.250 mmHg), clinically significant arrhythmias or
intolerance to the probe developed. For analysis, the left
ventricle was divided into 16 segments (41). A test was
considered positive when regional dyssynergy developed dur-
ing dobutamine infusion in one or more myocardial segments.
Quantitative analysis of the myocardial response to dobut-
amine. In patients with chest pain, despite normal coronary
arteriograms and in normal control subjects, the contractile
response to dobutamine was assessed quantitatively by mea-
suring myocardial systolic thickening using the method de-
scribed in detail in Figure 1.
For the purpose of comparison between the two groups,
measurements from 100 myocardial chords were averaged and
the percent increase in systolic thickening at each of four
incremental doses of dobutamine (10, 20, 30 and 40 mg/kg per
min) was calculated using the formula: percent increase in
systolic thickening with dobutamine5 (systolic thickening with
dobutamine 2 systolic thickening at baseline)/(systolic thick-
ening at baseline) 3 100.
In addition, to assess the response of different myocardial
regions in patients with chest pain and normal coronary
arteries, the left ventricle was divided into six segments corre-
sponding to the anterior and posterior ventricular septum and
the anterior, lateral, posterior and inferior free walls (Fig. 1A,
D). For the purpose of this analysis, the myocardial chords
within each segment were averaged, and systolic thickening
was calculated as described earlier.
Statistical analysis. Two means were compared using the
paired or unpaired Student t test, as appropriate. Proportions
were compared using the chi-square test. Comparison of the
quantitative myocardial response to increasing doses of dobut-
amine between patients with chest pain, despite normal coro-
nary arteriograms, and control subjects was performed with
analysis of variance for repeated measures. Correlations were
assessed by means of the Pearson correlation coefficient. Data
are presented as mean 6 SD, except where indicated. A p
value ,0.05 was considered significant.
Results
Exercise test. The results of the exercise treadmill tests are
summarized in Table 1. Compared with the normal control
subjects, patients with chest pain and normal coronary arterio-
grams had a greater incidence of chest pain (56 [80%] of 70
patients vs. 0 [0%] of 26 patients, p , 0.0001) and were more
likely to develop repolarization abnormalities (22 [31%] of 70
patients vs. 4 [15%] of 26 patients) during exercise testing,
although the latter difference did not reach statistical signifi-
cance (p 5 0.18).
Radionuclide studies. Ten (16%) of the 62 patients who
underwent radionuclide studies had a decrease in ejection
fraction with exercise; in three patients this response was
accompanied by the development of regional wall motion
abnormalities. Eleven (18%) of the 62 patients had reversible
thallium perfusion defects on the stress images. Only 1 of the
62 patients had both a decrease in ejection fraction with
exercise and reversible thallium defects. The findings of the
radionuclide studies were not related to the presence of
ischemic-appearing repolarization changes on the exercise
treadmill test. Thus, a positive exercise test was found in 17
(33%) of 52 patients with an increase and in 3 (30%) of 10
patients with a decrease in ejection fraction during exercise
(p 5 0.84). Similarly, a positive exercise test was observed in 4
(36%) of 11 patients with and in 16 (31%) of 51 patients
without reversible defects on thallium scintigraphy (p 5 0.97).
Transesophageal dobutamine stress echocardiography.
The results of the dobutamine stress test are summarized in
Table 2. Fifty-nine (84%) of the 70 patients developed chest
pain during infusion of dobutamine. In each case, the chest
pain provoked during the test was similar in nature to that
experienced during the patients’ daily activities. Twenty-four
(34%) of the 70 patients also developed repolarization abnor-
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malities compatible with myocardial ischemia during the do-
butamine stress test. Nineteen (86%) of the 22 patients with
repolarization abnormalities induced by exercise testing also
developed ischemic-appearing changes on the ECG with do-
butamine. The prevalence of chest pain and ST segment
depression during the dobutamine test was similar between
men and women with chest pain and normal coronary angio-
grams (chest pain: 22 [85%] of 26 men and 37 [84%] of 44
women, p 5 0.78; ST segment depression: 7 [27%] of 26 men
and 17 [39%] of 44 women, p 5 0.46). None of the 70 patients
developed regional wall motion abnormalities compatible with
myocardial ischemia (Fig. 2).
None of the control subjects developed chest pain during
infusion of dobutamine. Two control subjects (8%) developed
1-mm ST segment depression and one additional individual
had inversion of T waves in the inferior leads. None of the
Figure 1. Centerwall analysis for quantitative assessment of systolic
thickening from the transgastric short-axis view at the midventricular
level. Analysis was performed using commercially available software
included in the Image Vue system (Nova Microsonics). At baseline and
during the infusion of dobutamine at 10, 20, 30 and 40 mg/kg per min,
the end-diastolic and end-systolic frames were identified as those
showing the maximal and minimal left ventricular cavity size, respec-
tively, during the cardiac cycle. In this example, the image shown is an
end-diastolic frame recorded during baseline conditions. First, elec-
tronic markers are placed on the endocardial and epicardial borders
(A). For anatomic reference, the first marker is always placed on the
anterior junction of the right ventricular and left ventricular walls
(arrow) and subsequent markers are placed in clockwise fashion.
Following the markers, the computer traces the endocardial and
epicardial contours, and a centerwall line that, at each point, is
equidistant from the endocardium and epicardium (B). Perpendicular
to this centerwall line, 100 chords are traced extending from the
epicardium to the endocardium; these chords represent the myocardial
thickness at end-diastole (C). The same methodology is followed for
the assessment of wall thickness on the end-systolic frame (not shown).
Myocardial systolic thickening is then derived as the difference be-
tween end-systolic thickness minus end-diastolic thickness for each
individual chord. Importantly, because assumptions about the location
of the center of mass of the left ventricle are not necessary, this
methodology is not affected by cardiac translation of the heart during
the cardiac cycle. Using customized software, data are subsequently
transferred to a desktop computer, which allows the graphic display of
the endocardial and epicardial contours in diastole and systole as well
as the degree of systolic thickening for the 100 myocardial chords (D).
Parts A and D also show the segmentation of the left ventricle for
analysis of regional wall motion. AFW 5 anterior free wall; AS 5
anterior septum; IFW 5 inferior free wall; LFW 5 lateral free wall;
PFW 5 posterior free wall; PS 5 posterior septum.
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normal control subjects developed regional wall motion abnor-
malities during the dobutamine stress test.
Quantitative myocardial response to dobutamine. No dif-
ference was observed in the quantitative assessment of the
myocardial response to incremental doses of dobutamine
between patients and control subjects. As shown in Figure 3,
the increase in myocardial systolic thickening from the values
obtained at baseline was similar in both groups at each dose of
dobutamine analyzed. Based on the results obtained in the
group of normal volunteers, we estimated a difference of 25%
in percent systolic wall thickening at 40 mg/kg per min of












Basal heart rate 76 6 14 71 6 9 NS
Peak 158 6 19 161 6 19 NS
Blood pressure (mm Hg)
Basal
Systolic 131 6 17 137 6 16 NS
Diastolic 76 6 12 71 6 8 NS
Peak
Systolic 187 6 43 189 6 24 NS
Diastolic 79 6 15 72 6 14 NS
Chest pain 56 (80%) 0 (0%) ,0.0001
ST segment depression 22 (31%) 4 (15%) 0.18
Data presented are mean value 6 SD or number (%) of patients.














Completion of test 51 24
Severe chest pain 13 0
Severe hypertension 3 0
Arrhythmias 1 0
Wall motion defects 0 0
Intolerance 2 2
Max dose (mg/kg per min) 34.66 9.7 37.56 6.0 NS
Heart rate (beats/min)
Basal 816 13 796 9 NS
Peak 1476 17 1396 16 ,0.05
Blood pressure (mm Hg)
Basal
Systolic 1326 19 1366 15 NS
Diastolic 776 13 726 7 NS
Peak
Systolic 1736 29 1756 22 NS
Diastolic 786 14 716 13 NS
Chest pain 59 (84%) 0 (0%) ,0.0001
ST segment depression 24 (34%) 2 (8%) ,0.02
Wall motion abnormalities 0 (0%) 0 (0%) NS
Data presented are mean value 6 SD, number of patients or number (%) of
patients.
Figure 2. Example of the ECG and echocardiographic features ob-
served during infusion of dobutamine in a patient with coronary artery
disease (top) and a patient with chest pain and normal coronary
arteries (bottom). For each patient, one ECG lead obtained before and
during the peak dose of dobutamine is shown on the top panels. On
the bottom panels are the end-systolic frames obtained from the
short-axis view at baseline and during the infusion of the peak dose of
dobutamine. The patient with coronary artery disease had significant
ST segment depression with infusion of dobutamine that was accom-
panied by the development of hypokinesia in the interventricular
septum. Coronary angiography demonstrated significant stenosis of
the left anterior descending coronary artery. The patient with chest
pain and normal coronary arteries also had development of repolar-
ization abnormalities with infusion of dobutamine. However, no
regional wall motion abnormalities developed; instead, there was a
homogeneous increase in systolic thickening of all segments. RV 5
right ventricle.
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dobutamine as clinically meaningful. A power analysis showed
that, at the maximal dose of dobutamine, our study had an
80% power to detect a difference in percent increase in systolic
wall thickening of 25%. Further, within each group, the
quantitative myocardial response to dobutamine was similar in
subjects with and without ischemic-appearing repolarization
changes during exercise testing (Fig. 4).
In the group of patients with chest pain despite normal
coronary arteriograms, no regional differences were observed
in the inotropic response to dobutamine of the different
myocardial segments (Fig. 5). In these patients, no relation was
observed between the inotropic response to dobutamine (ex-
pressed as percent increase in systolic thickening at the highest
dose) and either age (r5 20.19) or gender (1276 60% in men
vs. 122 6 55% in women).
Discussion
Findings of the present study. The present study demon-
strates that angina-like chest pain, similar to that experienced
during daily activity, is commonly provoked with infusion of
dobutamine in patients with chest pain symptoms despite
normal coronary angiograms. Thus, 59 (84%) of the 70 study
patients developed their characteristic chest pain during infu-
sion of dobutamine, similar to the prevalence of pain reported
by these patients during treadmill exercise testing (80%).
Because the chest pain occurred after increases in myocardial
oxygen demands induced by both exercise and dobutamine
infusion, it is reasonable to assume a cardiac origin of their
complaint. However, despite the frequent provocation of chest
pain during dobutamine stress, none of the patients had
induced regional wall motion abnormalities, even though
Figure 3. Comparison of the quantitative myocardial response to the
infusion of incremental doses of dobutamine in normal control sub-
jects (open circles) and in patients with chest pain and a normal
coronary arteriogram (solid circles). In this and subsequent figures,
markers and error bars represent mean 6 SEM. The p value corre-
sponds to the comparison of the different responses using analysis of
variance for repeated measures.
Figure 4. Comparison of the quan-
titative myocardial response to the
infusion of incremental doses of
dobutamine in subjects with (solid
circles) and without (open circles)
development of ST segment de-
pression during exercise testing.
Patients with chest pain and nor-
mal coronary arteries are shown at
right, and normal control subjects
are shown at left.
Figure 5. Comparison of the quantitative myocardial response to
the infusion of incremental doses of dobutamine in six different left ven-
tricular segments analyzed from the short-axis view (see Fig. 1) in
patients with chest pain and normal coronary arteriograms. Solid
circles 5 anterior septum; open circles 5 posterior septum; solid
triangles 5 inferior free wall; open triangles 5 posterior free wall;
solid diamonds 5 lateral free wall; open diamonds 5 anterior free wall.
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one-third developed ischemic-appearing ECG repolarization
changes. Our findings, however, question whether myocardial
ischemia is a common cause of chest pain in these patients,
even in those who concomitantly develop repolarization ab-
normalities (the so-called syndrome X). Because most of the
high energy phosphates in the cardiac myocytes are used to
generate contraction, systolic dysfunction is an early phenom-
enon in the cascade of events that follow the induction of
myocardial ischemia (47,48). Therefore, it is highly unlikely
that ischemia developed in these patients without resulting in
even a minimal reduction in contractile function during the
increases in myocardial oxygen demands induced by dobut-
amine.
Comparison with findings of previous studies. Although
previous studies including small numbers of patients have
reported a lack of induced wall motion abnormalities during
stress echocardiography in patients with chest pain despite
normal coronary angiograms (25,36,37), the present investiga-
tion expands those observations using the transesophageal
approach, which allows enhanced visual assessment of myocar-
dial contraction responses to increases in oxygen demands. In
fact, this approach has rendered a higher sensitivity than the
conventional transthoracic examination for the demonstration
of myocardial ischemia in patients with coronary artery disease
(49,50) and has proved to have a very high specificity in several
previous studies using different forms of stress (41,42,51–54).
In addition, we used a quantitative analysis of the transmural
myocardial response. In our study, no wall motion abnormal-
ities were noted despite the frequent provocation of chest pain,
and no differences were observed in the quantitative increase
in systolic thickening between patients and healthy control
subjects. Our study also extends previous observations by
relating the echocardiographic results to those obtained during
conventional exercise ECG and nuclear testing in a large
number of consecutive patients referred for evaluation of
persistent chest pain despite normal coronary angiograms, thus
better defining the spectrum of noninvasive findings in these
subjects.
We and other investigators have previously reported limited
coronary blood flow responses to pacing stress, exacerbated by
ergonovine administration, and to pharmacologic agonists such
as dipyridamole and acetylcholine in subsets of patients with
angina-like chest pain but normal coronary angiograms (6–15).
Because of their normal coronary angiograms and the absence
of epicardial vasoconstriction during these studies, investiga-
tors concluded that many such patients had evidence of
coronary microvascular dysfunction that might limit appropri-
ate flow responses to stress, resulting in myocardial ischemia
and precipitation of angina pectoris. Evidence for ischemia in
these studies was generally provided by associated abnormal
noninvasive testing, which often initiated cardiac evaluation in
the first place.
The absence of evidence of myocardial ischemia during
dobutamine stress in our study, despite previous reports of
coronary microvascular dysfunction, could be a consequence of
one of the following: First, as proposed by Maseri et al. (21),
the hemodynamic consequence of inhomogeneous coronary
microvascular dysfunction might be compensated by vasodila-
tion of nearby microvessels, thereby either protecting the
ventricle from ischemia or minimizing the ischemic response to
the dysfunctional microvessels. If mild, diffuse ischemia were
provoked during dobutamine stress by this mechanism, isch-
emic effects on systolic contraction might not be detectable by
transesophageal echocardiography or any other currently
available technique. However, such minimal ischemia might be
expected to result in greater symptom responsiveness to anti-
ischemic therapy, which contradicts the general clinical expe-
rience in managing these patients (5). Second, myocardial
ischemia might have been provoked during dobutamine infu-
sion in our patients who experienced chest pain and, in many
cases, ischemic-appearing ECG repolarization changes, but
was missed because of our limitation in using a centerwall
analysis in a single short-axis plane at the mid-ventricular level.
Thus, we might have missed an ischemia-induced reduction in
transmural contraction of other regions, such as apical seg-
ments. This possibility is unlikely, however, given the homoge-
neous pattern of contraction during peak dobutamine infusion
observed in the qualitative analysis performed in all 16 seg-
ments of the left ventricle. Third, coronary microvascular
dysfunction might be provoked during exercise stress, thus
accounting for chest pain during exercise and abnormal non-
invasive test results compatible with ischemia, but not during
dobutamine stress. However, the abnormal findings of the
standard noninvasive tests used in our study (exercise testing,
radionuclide angiography and thallium scintigraphy) were ran-
domly distributed among patients, such that an abnormal
result in one test was not associated with a higher likelihood of
an abnormal result on another test. This observation strongly
suggests that those abnormal findings are not expressions of
induced myocardial ischemia, but rather represent false posi-
tive results of each test. Further, chest pain was as commonly
provoked during dobutamine stress as during exercise (84% vs.
80%), suggesting that the same mechanism responsible for
provoking pain in these patients was operative during both
studies. The higher prevalence of ischemic-appearing ECG
repolarization changes during exercise stress testing in patients
with chest pain and normal coronary angiograms than in
healthy control subjects in our study likely represents a selec-
tion bias, because patients with repolarization changes com-
patible with myocardial ischemia are more likely to undergo
cardiac catheterization, particularly if they complain of angina-
like chest pain. Finally, it is also possible that the chest pain
experienced by the patients during treadmill exercise and
dobutamine infusion may not have been related to a cardiac
origin. An alternative consideration in attempting to resolve
the apparent discrepancy between our results and previous
reports of abnormal coronary microvascular function is that
measurements of coronary microvascular dynamics might have
been misinterpreted by the investigators as being abnormal
because of the absence of appropriate healthy control subjects
who cannot undergo similar invasive studies of coronary blood
flow. Further, studies not finding an association between
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“abnormal” coronary flow responses to some pharmacologic
agonist and “abnormal” noninvasive testing might not have
been published.
Study limitations. Transesophageal dobutamine stress
echocardiography has a reported sensitivity of 82% to 89% for
the detection of significant coronary stenoses (41,42), and thus
fails to induce myocardial ischemia in ;11% to 18% of
patients with coronary artery disease. Therefore, it is theoret-
ically possible that in using this technique we may have missed
myocardial ischemia in a similar proportion of patients with
chest pain and normal coronary arteriograms. This reasoning
does not explain the findings of a consistent lack of regional
wall motion abnormalities and normal quantitative myocardial
contractile response in our study patients. It must be pointed
out, however, that our study did not include patients with chest
pain despite normal coronary angiograms who had left bundle
branch block or depressed global left ventricular function at
rest. Therefore, we cannot exclude the possibility of an isch-
emic basis for the occurrence of chest pain in this subset of
patients, who are more likely to show deterioration in left
ventricular systolic function during clinical follow-up (55).
Conclusions. Our observation that dobutamine stress com-
monly provokes chest pain in the absence of left ventricular
functional evidence of myocardial ischemia supports the con-
cept of abnormal cardiac pain perception as being of para-
mount clinical importance in these patients, and thus is
consistent with previous reports demonstrating altered cardiac
nociception as a potential source of chest pain in this patient
population (28–33). Accordingly, dobutamine stress echocar-
diography may be a useful method of identifying patients
whose chest pain can be provoked without evidence of myo-
cardial ischemia and who can be managed more effectively with
therapy directed at treating abnormal cardiac nociception (28)
than with anti-ischemic therapy.
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